These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 29061101)

  • 1. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Nanocarriers for Anticancer Drugs Delivery.
    Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
    Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial nanoparticles for cancer diagnosis and therapy.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    Curr Med Chem; 2012; 19(22):3714-21. PubMed ID: 22680922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-based stimuli-responsive nanosystems for biomedical applications.
    Joglekar M; Trewyn BG
    Biotechnol J; 2013 Aug; 8(8):931-45. PubMed ID: 23843342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
    Xu J; Liao K; Jiang H; Zhou W
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation for Cancer Therapy.
    Montané X; Bajek A; Roszkowski K; Montornés JM; Giamberini M; Roszkowski S; Kowalczyk O; Garcia-Valls R; Tylkowski B
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
    Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
    Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
    Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
    Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.